Imatinib-Induced Bone Edema: Case Report and Review of Literature

Restricted access

Imatinib mesylate represents a revolution in the management of patients with metastatic gastrointestinal stromal tumors (GISTs). More recently, postoperative imatinib has been shown to improve both disease-free and overall survivals in patients with a high risk of recurrence. This article presents a well-documented case of a patient with painful and reversible bone edema related to imatinib.

Correspondence: Lucas Vieira dos Santos, MD, Hemomed - Instituto de Oncologia e Hematologia & IEP Sao Lucas, 121 Arnolfo de Azevedo Ave, Sao Paulo, Brazil 01236-030. E-mail:

Supplementary Materials

    • Supplemental Material (PDF 263 KB)